Press release
RNA Interference (RNAi) Drug Delivery Market to Witness Robust Expansion Throughout the Forecast Period 2015-2021
RNAi has application in the areas of therapeutics, drug delivery, research and development and agriculture. The therapeutics application of RNAi includes metabolic disorders, cardiology, neurology, oncology and ophthalmology.
To View Complete Report @ : http://www.persistencemarketresearch.com/market-research/rna-interference-drug-delivery-market.asp
The global RNAi market is categorized based on various types of drug delivery technologies and by therapeutic application. The drug delivery segment is further sub-segmented into nanoparticle drug delivery technology, pulmonary drug delivery technology, nucleic acid drug delivery technology and aptamer drug delivery technology. Nanoparticle drug delivery technology is the largest sub-segment in global RNAi drug delivery market. However, aptamer drug delivery technology is the fastest growing sub-segment in global RNAi drug delivery market.
A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/3511
Therapeutic segment includes infectious diseases, cardiology, oncology, neurology, ophthalmology and metabolic disorders.
In terms of geographic, North America and Europe dominates the global RNAi drug delivery market. This is due to improved life science research infrastructures in these regions. The U.S. represents the largest market for RNAi drug delivery technologies followed by Canada in North America. In Europe, France, Germany, Spain and the U.K. holds major share of RNAi drug delivery market. However, Asia is expected to show high growth rates in the next five years in global RNAi drug delivery market due to increased investment by major companies in the region. Japan, China and India are expected to be the fastest growing RNAi drug delivery markets in Asia.
To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/3511
In recent time, increasing prevalence of diseases, such as cancer and cardiovascular diseases, and innovative applications of the drug delivery technologies are some of the major drivers of the global RNAi drug delivery market. For instance, aptamer drug delivery technology offers several advantages compared to protein and small-molecule drugs, such as low risk of side-effects and complications in humans and enhanced their drug like properties including improved stability and residence time in the bloodstream.
In addition, increased research in the field of RNA therapeutics has also fueled the growth of global RNAi drug delivery market. However, high investment cost and stringent regulations are some of the major restraints for the global RNAi drug delivery market. In addition, targeted delivery of RNA molecules is key challenge for the global RNAi drug delivery market. Many companies engaged in developing RNA therapeutics are facing difficulties in delivery of RNA molecules to specific tissues to bring about a therapeutic effect. Increased research in the field of nanotechnology develops opportunity for the global RNAi drug delivery market. Increasing mergers and collaborations between life sciences companies and government research organizations is key trend for the global RNAi drug delivery market.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release RNA Interference (RNAi) Drug Delivery Market to Witness Robust Expansion Throughout the Forecast Period 2015-2021 here
News-ID: 655910 • Views: …
More Releases from Persistence Market Research
North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
Overview of the North America Wiring Devices Market
The North America wiring devices market is poised for steady growth over the forecast period, with its size estimated at US$ 18.96 billion in 2024, projected to reach US$ 26.46 billion by 2031, reflecting a CAGR of 4.9%. The market is witnessing substantial expansion due to increasing urbanization, a rising number of residential and commercial construction projects, and the adoption of energy-efficient and…
Global Forged Automotive Components Market Poised for Steady Growth, Projected t …
The global forged automotive components market is on a robust growth trajectory, currently valued at approximately US$ 50.3 billion in 2025 and forecasted to expand to US$ 70.7 billion by the end of 2032. This growth represents a compound annual growth rate (CAGR) of 5.0% over the coming decade, driven by increasing automotive production, technological advancements, and evolving consumer preferences toward durable, high-performance vehicle parts.
Forged automotive components are critical to…
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ …
The global electric cargo bike market is set to experience substantial growth over the coming decade, with Persistence Market Research (PMR) forecasting a compound annual growth rate (CAGR) of 11.9% from 2023 through 2032. Valued at approximately US$ 800 million in 2021, the market is expected to surge to a projected valuation of US$ 2.14 billion by the end of 2032. Notably, electric cargo bikes accounted for 66.2% of the…
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Drive …
The global bicycle bearings market is poised for significant expansion over the forecast period of 2025 to 2032, according to the latest report released by Persistence Market Research. Valued at approximately US$ 5.99 billion in 2024, the market is projected to reach US$ 6.35 billion by 2025 and further escalate to nearly US$ 9.86 billion by 2032. This growth trajectory reflects a compound annual growth rate (CAGR) of 6.5%, underscoring…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
